TSMHT
ZBH icon

Thurston Springer Miller Herd & Titak’s Zimmer Biomet ZBH Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$182 – 1394
2025
Q2 		$182 Hold
2
– – ﹤0.01% 1606
2025
Q1 		$226 Sell
2
-38
-95% -$4.07K ﹤0.01% 1630
2024
Q4 		$4.22K Buy
40
+38
+1,900% +$4.08K ﹤0.01% 1049
2024
Q3 		$215 Hold
2
– – ﹤0.01% 1505
2024
Q2 		$217 Buy
+2
New +$236 ﹤0.01% 1489

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's ZBH Position: Q3 2025 in Review

Thurston Springer Miller Herd & Titak sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 2 shares — an estimated $182 sold.

Thurston Springer Miller Herd & Titak first reported a position in ZBH in Q2 2024 and held it in 5 quarters. The position peaked at $4.22K in Q4 2024. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

  • Thurston Springer Miller Herd & Titak reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 2 Zimmer Biomet shares in Q3 2025, an estimated $182.
  • Thurston Springer Miller Herd & Titak first reported a position in Zimmer Biomet in Q2 2024 and held it in 5 quarters.
  • Thurston Springer Miller Herd & Titak's Zimmer Biomet position peaked at $4.22K in Q4 2024.
  • 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q3 2025, filed 7 Oct 2025.